The four new codes, with their short description, are:
- Q2041 — Wilate injection
- Q2042 — Hydroxyprogesterone caproate
- Q2043 — Sipuleucel-T auto CD54+
- Q2044 — Belimumab injection
The new codes have an MPFSDB status indicator of E.
CMS also announced it will no longer reimburse for J7184 (Wilate injection) effective for claims with dates of service on or after July 1.
View the CMS transmittal (2207) announcing the HCPCS code changes (pdf).
Related Articles on Coding:
Medicare Designates Four New K Codes for Billing Suction Pumps and Surgical Dressings
ICD-10 Straight Talk: Overview
Drug Code Changes Included in July HCPCS Level II Updates
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
